Insulin Resistance Linked to Ovulation Disorders in Women

Insulin resistance—a condition where cells fail to respond effectively to insulin—can substantially interfere with normal ovarian function, according to medical research. When the body develops resistance to insulin, it compensates by producing elevated levels of the hormone, which subsequently triggers increased production of androgens, male hormones present in women's bodies.

This hormonal imbalance directly affects the delicate mechanisms governing ovulation. Elevated androgen levels can prevent eggs from developing and releasing properly, resulting in irregular periods and anovulation—the absence of ovulation. The condition is particularly pronounced among women with PCOS, a common endocrine disorder affecting reproductive-age women across South Asia.

Insulin resistance disrupts the normal signaling pathways that regulate the menstrual cycle and egg maturation. The hormonal disruption creates a cycle where irregular ovulation becomes both a symptom and a complication, potentially affecting fertility and requiring medical intervention.

For women experiencing irregular periods or fertility challenges, understanding the role of insulin resistance has become increasingly important. Medical professionals now routinely screen for insulin resistance in PCOS patients and other women with ovulatory disorders, as addressing the underlying metabolic condition may help restore reproductive regularity and improve fertility outcomes.